THE WORLD'S FOREMOST IMAGING CORE LAB
Founded in 1990, Bio-Imaging Technologies,
Inc. (BITI) is the world's
largest independent, dedicated provider of medical image management
for clinical trials. Bio-Imaging continues to make large strides
in development, and we are continually looking for the latest
ways to remain in our position as the leading provider of medical
image management. On December 13, 2004, we were pleased to announce
the acquisition of Heart Core B.V. Located in Leiden, The Netherlands,
only 500 metres from our European operations, Heart Core is a leading
Global Provider of Cardiovascular, Pulmonary and Orthopedic clinical
research. With this acquisition, Bio-Imaging is positioned to offer
even more extensive services and scientific expertise to its clients.
As the leaders in the industry we offer an unmatched array of resources, capabilities, and experienced professionals to help you maximize the statistical power of your image data, meet your timelines and budget, and obtain regulatory approval. And, as a publicly-traded company, Bio-Imaging incorporates the controls of a government regulated firm to further your trust in our services.
Today's regulatory guidance dictates that image data be treated with the same rigor applied to clinical data. Bio-Imaging specializes in meeting these requirements. Our ability to manage the entire imaging process ensures quality, accuracy and compliance in every detail, from your initial consultation to your final submission.
Global Capabilities, Extensive Expertise
We've made more FDA submissions than any other Imaging Core Lab (ICL). Our team has processed over a million images from thousands of sites across five continents. We're conversant in all imaging modalities. You can rest assured that whether we're preparing a site in California or submitting images from China, your data is in the hands of experts.
Call Bio-Imaging Technologies for a free consultation and discover how we can assist you with the imaging dimensions of your next clinical trial.
|
"Our Mission is
to
provide
scientific
expertise
with operational
excellence."
Mark Weinstein,
President and CEO
|